Nicholas M Schlaeger

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Melanoma is the most aggressive form of skin cancer. Current challenges to melanoma therapy include the adverse effects from immunobiologics, resistance to drugs targeting the MAPK pathway, intricate interaction of many signal pathways, and cancer heterogeneity. Thus combinational therapy with drugs targeting multiple signaling pathways becomes a new(More)
  • 1